MecaserminGH BoosterSafety Rating 8/10
Primary research areaSevere primary IGF-1 deficiency
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range0.04-0.12 mg/kg twice daily
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Increlex)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Mecasermin
Mechanism of action
Recombinant human IGF-1; stimulates linear growth
Safety profile
Hypoglycemia, intracranial hypertension, acromegaly features · FDA-approved for IGF-1 deficiency; hypoglycemia risk; intracranial hypertension rare
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Mecasermin below your target.
Related pages